{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:39:35Z","timestamp":1790627975292,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Childs Nerv Syst"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00381-021-05127-6","type":"journal-article","created":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T04:03:26Z","timestamp":1616385806000},"page":"1909-1915","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Trametinib for orbital plexiform neurofibromas in young children with neurofibromatosis type 1"],"prefix":"10.1007","volume":"37","author":[{"given":"Helen","family":"Toledano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gad","family":"Dotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rivka","family":"Friedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rony","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iftach","family":"Yassur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit","family":"Toledano-Alhadef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomi","family":"Constantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika Shapira","family":"Rootman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"issue":"4","key":"5127_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00401-019-02002-2","volume":"139","author":"JS Nix","year":"2019","unstructured":"Nix JS, Blakeley J, Rodriguez FJ (2019) An update on the central nervous system manifestations of neurofibromatosis type 1. Acta Neuropathol 139(4):625\u2013641. https:\/\/doi.org\/10.1007\/s00401-019-02002-2","journal-title":"Acta Neuropathol"},{"key":"5127_CR2","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/ICU.0b013e32836348a4","volume":"24","author":"NG Gandhi","year":"2013","unstructured":"Gandhi NG (2013) Treatment of neuro-ophthalmic and orbitofacial manifestations of neurofibromatosis type 1. Curr Opin Ophthalmol 24:506\u2013511. https:\/\/doi.org\/10.1097\/ICU.0b013e32836348a4","journal-title":"Curr Opin Ophthalmol"},{"key":"5127_CR3","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.survophthal.2017.10.007","volume":"63","author":"M Kinori","year":"2018","unstructured":"Kinori M, Hodgson N, Zeid JL (2018) Ophthalmic manifestations in neurofibromatosis type 1. Surv Ophthalmol 63:518\u2013533. https:\/\/doi.org\/10.1016\/j.survophthal.2017.10.007","journal-title":"Surv Ophthalmol"},{"key":"5127_CR4","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/J.CURRPROBLCANCER.2018.01.007","volume":"42","author":"M Khajavi","year":"2018","unstructured":"Khajavi M, Khoshsirat S, Ahangarnazari L, Majdinasab N (2018) A brief report of plexiform neurofibroma. Curr Probl Cancer 42:256\u2013260. https:\/\/doi.org\/10.1016\/J.CURRPROBLCANCER.2018.01.007","journal-title":"Curr Probl Cancer"},{"key":"5127_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/(sici)1096-8628(19990326)89:1<31::aid-ajmg7>3.0.co;2-w","volume":"89","author":"BR Korf","year":"1999","unstructured":"Korf BR (1999) Plexiform neurofibromas. Am J Med Genet 89:31\u201337. https:\/\/doi.org\/10.1002\/(sici)1096-8628(19990326)89:1<31::aid-ajmg7>3.0.co;2-w","journal-title":"Am J Med Genet"},{"key":"5127_CR6","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.ophtha.2003.05.029","volume":"111","author":"V Lee","year":"2004","unstructured":"Lee V, Ragge NK, Collin JRO (2004) Orbitotemporal neurofibromatosis. Ophthalmology 111:382\u2013388. https:\/\/doi.org\/10.1016\/j.ophtha.2003.05.029","journal-title":"Ophthalmology"},{"key":"5127_CR7","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/eye.2011.336","volume":"26","author":"IA Chaudhry","year":"2012","unstructured":"Chaudhry IA, Morales J, Shamsi FA, al-Rashed W, Elzaridi E, Arat YO, Jacquemin C, Oystreck DT, Bosley TM (2012) Orbitofacial neurofibromatosis: clinical characteristics and treatment outcome. Eye (Lond) 26:583\u2013592. https:\/\/doi.org\/10.1038\/eye.2011.336","journal-title":"Eye (Lond)"},{"key":"5127_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ophtha.2016.09.020","volume":"124","author":"RA Avery","year":"2017","unstructured":"Avery RA, Katowitz JA, Fisher MJ, Heidary G, Dombi E, Packer RJ, Widemann BC, Hutcheson KA, Madigan WP, Listernick R, Liu GT, Berland JE, FitzGibbon EJ, Korf BR (2017) Orbital\/periorbital plexiform neurofibromas in children with neurofibromatosis type 1: multidisciplinary recommendations for care. Ophthalmology 124:123\u2013132. https:\/\/doi.org\/10.1016\/j.ophtha.2016.09.020","journal-title":"Ophthalmology"},{"key":"5127_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/BPO.0b013e31820cad77","volume":"31","author":"F Canavese","year":"2011","unstructured":"Canavese F, Krajbich JI (2011) Resection of Plexiform neurofibromas in children with neurofibromatosis type 1. J Pediatr Orthop 31:303\u2013311. https:\/\/doi.org\/10.1097\/BPO.0b013e31820cad77","journal-title":"J Pediatr Orthop"},{"key":"5127_CR10","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.bjps.2016.10.015","volume":"70","author":"S Keren","year":"2017","unstructured":"Keren S, Dotan G, Ben-Cnaan R, Leibovitch L, Leibovitch I (2017) A combined one-stage surgical approach of orbital tumor debulking, lid reconstruction, and ptosis repair in children with orbitotemporal neurofibromatosis. J Plast Reconstr Aesthet Surg 70:336\u2013340. https:\/\/doi.org\/10.1016\/j.bjps.2016.10.015","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"5127_CR11","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1148\/rg.2018180109","volume":"38","author":"J AlRayahi","year":"2018","unstructured":"AlRayahi J, Zapotocky M, Ramaswamy V, Hanagandi P, Branson H, Mubarak W, Raybaud C, Laughlin S (2018) Pediatric brain tumor genetics: what radiologists need to know. RadioGraphics 38:2102\u20132122. https:\/\/doi.org\/10.1148\/rg.2018180109","journal-title":"RadioGraphics"},{"key":"5127_CR12","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1056\/nejmoa1605943","volume":"375","author":"E Dombi","year":"2016","unstructured":"Dombi E, Baldwin A, Marcus LJ, Fisher MJ, Weiss B, Kim AR, Whitcomb P, Martin S, Aschbacher-Smith LE, Rizvi TA, Wu J, Ershler R, Wolters P, Therrien J, Glod J, Belasco JB, Schorry E, Brofferio A, Starosta AJ, Gillespie A, Doyle AL, Ratner N, Widemann BC (2016) Activity of selumetinib in neurofibromatosis type 1\u2013related plexiform neurofibromas. N Engl J Med 375:2550\u20132560. https:\/\/doi.org\/10.1056\/nejmoa1605943","journal-title":"N Engl J Med"},{"key":"5127_CR13","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/nejmoa1912735","volume":"382","author":"AM Gross","year":"2020","unstructured":"Gross AM, Wolters PL, Dombi E, Baldwin A, Whitcomb P, Fisher MJ, Weiss B, Kim AR, Bornhorst M, Shah AC, Martin S, Roderick MC, Pichard DC, Carbonell A, Paul SM, Therrien J, Kapustina O, Heisey K, Clapp DW, Zhang C, Peer CJ, Figg WD, Smith M, Glod J, Blakeley JO, Steinberg SM, Venzon DJ, Doyle LA, Widemann BC (2020) Selumetinib in children with inoperable plexiform neurofibromas. N Engl J Med 382:1430\u20131442. https:\/\/doi.org\/10.1056\/nejmoa1912735","journal-title":"N Engl J Med"},{"key":"5127_CR14","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1186\/s12885-019-6442-2","volume":"19","author":"S Perreault","year":"2019","unstructured":"Perreault S, Larouche V, Tabori U, Hawkin C, Lipp\u00e9 S, Ellezam B, D\u00e9carie JC, Th\u00e9oret Y, M\u00e9tras M\u00c9, Sultan S, Cantin \u00c9, Routhier M\u00c8, Caru M, Legault G, Bouffet \u00c9, Lafay-Cousin L, Hukin J, Erker C, Jabado N (2019) A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK\/ERK pathway: TRAM-01. BMC Cancer 19:1250. https:\/\/doi.org\/10.1186\/s12885-019-6442-2","journal-title":"BMC Cancer"},{"key":"5127_CR15","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1093\/neuonc\/noaa053","volume":"22","author":"S Akshintala","year":"2020","unstructured":"Akshintala S, Baldwin A, Liewehr DJ, Goodwin A, Blakeley JO, Gross AM, Steinberg SM, Dombi E, Widemann BC (2020) Longitudinal evaluation of peripheral nerve sheath tumors in neurofibromatosis type 1: growth analysis of plexiform neurofibromas and distinct nodular lesions. Neuro-Oncology 22:1368\u20131378. https:\/\/doi.org\/10.1093\/neuonc\/noaa053","journal-title":"Neuro-Oncology"},{"key":"5127_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/neuonc\/now158","volume":"19","author":"RI Jakacki","year":"2017","unstructured":"Jakacki RI, Dombi E, Steinberg SM, Goldman S, Kieran MW, Ullrich NJ, Pollack IF, Goodwin A, Manley PE, Fangusaro J, Allen R, Widemann BC (2017) Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas. Neuro-Oncology 19:289\u2013297. https:\/\/doi.org\/10.1093\/neuonc\/now158","journal-title":"Neuro-Oncology"},{"key":"5127_CR17","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/pbc.24873","volume":"61","author":"B Weiss","year":"2014","unstructured":"Weiss B, Widemann BC, Wolters P, Dombi E, Vinks AA, Cantor A, Korf B, Perentesis J, Gutmann DH, Schorry E, Packer R, Fisher MJ (2014) Sirolimus for non-progressive NF1-associated plexiform neurofibromas: an NF clinical trials consortium phase II study. Pediatr Blood Cancer 61:982\u2013986. https:\/\/doi.org\/10.1002\/pbc.24873","journal-title":"Pediatr Blood Cancer"},{"key":"5127_CR18","doi-asserted-by":"publisher","first-page":"10504","DOI":"10.1200\/jco.2018.36.15_suppl.10504","volume":"36","author":"GB McCowage","year":"2018","unstructured":"McCowage GB, Mueller S, Pratilas CA et al (2018) Trametinib in pediatric patients with neurofibromatosis type 1 (NF-1)\u2013associated plexiform neurofibroma: a phase I\/IIa study. J Clin Oncol 36:10504\u201310504. https:\/\/doi.org\/10.1200\/jco.2018.36.15_suppl.10504","journal-title":"J Clin Oncol"},{"key":"5127_CR19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1055\/s-0039-1691830","volume":"50","author":"P Vaassen","year":"2019","unstructured":"Vaassen P, D\u00fcrr N, R\u00f6hrig A, Willing R, Rosenbaum T (2019) Trametinib induces neurofibroma shrinkage and enables surgery. Neuropediatrics 50:300\u2013303. https:\/\/doi.org\/10.1055\/s-0039-1691830","journal-title":"Neuropediatrics"},{"key":"5127_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/pde.13038","volume":"34","author":"C Boull","year":"2017","unstructured":"Boull C, Hook K, Moertel C, Maguiness S (2017) Cutaneous reactions in children treated with the mitogen-activated protein kinase extracellular signal-regulated kinase inhibitor trametinib for neural tumors. Pediatr Dermatol 34:90\u201394. https:\/\/doi.org\/10.1111\/pde.13038","journal-title":"Pediatr Dermatol"},{"key":"5127_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S1470-2045(19)30277-3","volume":"20","author":"J Fangusaro","year":"2019","unstructured":"Fangusaro J, Onar-Thomas A, Young Poussaint T, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Qaddoumi I, Jakacki RI, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle LA, Smith M, Dunkel IJ, Fouladi M (2019) Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol 20:1011\u20131022","journal-title":"Lancet Oncol"}],"container-title":["Child's Nervous System"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-021-05127-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00381-021-05127-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00381-021-05127-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T15:09:33Z","timestamp":1623078573000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00381-021-05127-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["5127"],"URL":"https:\/\/doi.org\/10.1007\/s00381-021-05127-6","relation":{},"ISSN":["0256-7040","1433-0350"],"issn-type":[{"value":"0256-7040","type":"print"},{"value":"1433-0350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,22]]},"assertion":[{"value":"14 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The local institutional review board of the Rabin Medical Center and the Israeli Ministry of Health approved the study. We certify that the study was performed in accordance with the ethical standards as laid down in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all parents before treatment. Informed consent for publication of data and photographic material was obtained from all parents.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/publish"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}